MODULE VI
PAIN MANAGEMENT
Objectives: Objectives:
- Describe various drugs used for pain management according to
classification, mechanisms of action, indications,
contraindications, adverse effects, and interactions.
- Explain the basic principles of pain
management in regard to choice and strength of drug, and dosing schedules.
- Calculate dose equivalents for opoid
analgesics.
- Differentiate between therapy appropriate
for acute and chronic pain.
- Discuss issues of drug dependence and
abuse.
Resources:
Text:
Katzung, chapters 27, 31, 32, 36
Kuhn, chapters 18, 22, 57, 67
LSUMC videotapes
Web-based resources:
From Stanford University available at:
http://www-med.stanford.edu
Primary care teaching module:
Knee and hip pain.
The Migraine Treatment Center of the
American Medical Association is
available at:
http://www.ama-assn.org/special/migraine/
treatmnt/guidecan.htm
From the American Academy of Family
Practice at z:
http://www.aafp.org
Carpenter, R. (1997). Optimizing
Postoperative Pain Management.
AmericanFamily Physician 56 (3):
Siwek, J. (1997). Twelve pitfalls of
adequate pain control. American
Family Physician 56(3):
From MEDSCAPE : http://www.medscape.com
No Author listed (1998) The management of
chronic pain in older persons:
New guidelines from the American Geriatrics Society. Clinician Reviews 8
(9): 69-72, 75-78, 81-82, 87-89, 94, 99, 103-104.
Campbell, S. (1998). Rheumatoid arthritis:
Current strategies. Hospital
Medicine 34(8):29-32, 39-40.
Cohen, J. (1996), Migraine headache and
the managed care formulary.
Drug Benefit Trends 8(8): 28-30, 33-34, 41.
Smith, T. (1998). Migraine prevention need
no longer be a headache. Hospital
Medicine 34 (10): 13-14, 19-21, 25.
From the Agency on Health Care Policy and
Review:
http://text.nlm.nih.gov
choose AHCPR supported guidelines on Acute
Pain Management in Adults:
Operative Procedures
Acute Low Back Problems In Adults:
Assessment and Treatment Managing
Cancer Pain
Study Guide:
1. Differentiate between acute and
chronic pain in terms of function, characteristics and nerve pain pathways.
2. Identify and describe nonopoid
analgesics in terms of drug classification, mechanisms of action, indications,
contraindications, adverse effects and drug interactions.
A. Acetominophen
B. Salicylates
C. NSAIDS
a. Propionic acid derivatives
b. Indole analogs
c. Oxicam drugs
d. Pyrazolone derivatives
e. Fenamate drugs
3. Visit a local pharmacy and complete the
following information regarding commonly used OTC pain relievers.
A. Acetominophen
(1) Trade names (2) Cost/dose (3) Cost/24 hr
pain relief
B. Ibuprofen
(1) Trade names (2) Cost/dose (3) Cost/24 hr
pain relief
C. Naproxyn Sodium
(1) Trade names (2) Cost/dose (3) Cost/24 hr
pain relief
D. Ketoprofen
(1) Trade names (2) Cost/dose (3) Cost/24 hr
pain relief
E. Aspirin
(1) Trade names (2) Cost/dose (3) Cost/24 hr
pain relief
F. Choline Salicylate
(1) Trade names (2) Cost/dose (3) Cost/24 hr
pain relief
G. Choline Magnesium Trisalicylate
(1) Trade names (2) Cost/dose (3) Cost/24 hr
pain relief
4. List the major therapeutic indications for use of NSAIDs
(other than pain relief) in clinical practice and indicate the
intended effect of NSAIDs
in each instance.
5. Describe the WHO stepped approach
to pain relief.
6. Differentiate among the ways that opiate and nonopiate pain
relievers, ergot derivatives and selective serotonin agonists
influence pain
relief.
7. Define the following terms:
a. agonist
b. antagonist
c. agonist-antagonist
d. endorphin
e. enkephalin
8. Differentiate between opiate tolerance and opiate
dependence.
9. Describe nonpharmacologic mechanisms by which
endogenous endorphins and enkephalin production can be
enhanced as an adjunct to pain relief.
10. Describe the effects of various opiates on receptor sites
found in
the central nervous system.
Receptor type
Physiologic Effect
Opiate/Endogenous Peptide-
Type of Activity
mu
kappa
sigma
delta
epsilon
11. Morphine is considered the gold standard for calculation of
equianalgesic effects of other opiates. Because the effects
of opiate
analgesics vary considerably between drugs as well as
between dosage
forms, it is
essential to understand the concept of equivalent dosing.
Complete the following table for practice
in determining equianalgesic dosing: (Assume adult patients weighing > 50 kg
with no opiate tolerance)
| Drug |
Appropriate
Equianalgesic dose |
Usual
starting dose for moderate to severe pain |
| Opioid
agonist |
Oral |
Parenteral |
Oral |
Parenteral |
| Morphine |
|
|
|
|
| Morphine,
controlled release (MS Contin,
Oramorph) |
|
|
|
|
| Hydromorphone (Dilaudid) |
|
|
|
|
| Levorphanol (Levo-Dromoran) |
|
|
|
|
| Meperidine (Demerol) |
|
|
|
|
| Methadone (Dolophine) |
|
|
|
|
| Propoxyphene (Darvon, Darvon-N) |
|
|
|
|
| Pentazocine
(Talwin) |
|
|
|
|
| Butorphanol
(Stadol) |
|
|
|
|
| Nalbuphine
(Nubain) |
|
|
|
|
| Buprenorphine
(Buprenex) |
|
|
|
|
| Oxymorphone (Numorphan) |
|
|
|
|
Combination opioid/NSAID preparations
| Codeine with
aspirin or acetominophen |
|
|
|
|
| Hydrocodone (in
Lorcet, Lortab, Vicodin, others) |
|
|
|
|
| Oxycodone (in
Percocet, Percodan, Tylox, others) |
|
|
|
|
12. Identify and describe at least two opiate antagonists according to
mechanism of action, indications. contraindications,
adverse effects
and
interactions.
Case Studies:
#1 Headache
Katie Lincoln is a 25 year old white
female who is seen in the clinic with complaints of recurrent severe headaches. She
describes these headaches
as throbbing, usually on the left side in the temple area, and are typically accompanied
by nausea and photophobia.. Pain is typically an 8 or 9 on a
10 point scale. Intensity and frequency of headaches have increased over
the last several months, and usually occur during her menses. Katie states that her
headache today is "terrible; I took two ibuprofen tablets about
1 1/2 hrs ago, and they haven't even touched it."
PMH: Previous workups for
aneurysm, tumor and infection have been negative, Otherwise, noncontributory
FH: Father 56, with NIDDM
and HTN. Mother died 3 years ago in MVA.
Social: Teaches first
grade. Smokes 1 ppd. Admits to occasional glass of wine, 2-3 times/month. Denies illegal
drug use. 1-2 cups of coffee daily;
4-5 diet cokes daily. No routine exercise program. Frequently skips
breakfast. NKDA
Meds: Desogen, 1 tablet
daily, began 6 months ago. Multivitamin daily, Ibuprofen prn
PE: Day 2 of menses,
otherwise all parameters, including vs and neuro are normal.
Lab: BS 98, UA negative.
1. Develop a differential diagnosis list
for Katie.
2. Assuming your most likely diagnosis is correct, what data in
the H &P support your
diagnosis?
3. Describe the options for abortive therapy for migraine
headaches.
4. Prescribe a therapeutic regimen for Katie, including patient
education and life style changes as well as pharmacologic
interventions.
5. After following your prescribed regimen for several months,
Katie tells you that she is somewhat better, but that she still
gets headaches for several days each month. She states she
had a friend with migraines who took a shot to prevent
them. She wants to know what she can do to prevent hers.
Describe the options for preventive therapy for migraine
headaches. Which of these options would be most
appropriate for Katie?
|